Almost everyone would want to remain young. It is this context that the team of researchers has been increasingly engaged in age reversal studies. There are studies which show that can delay aging and anti-aging a possibility. Some have further claimed that they have found the road to immortality.
A drug used in cancer treatment is found to have shown the signs of anti-aging in dogs, monkeys, and mice. The scientists believe that such results can also be identified in humans in near future. This drug can turn out to be the key for an anti-ageing solution for humans.
The drug used in cancer treatment that is found to result in anti-aging is Rapamycin. It is a drug that is taken by cancer patients and organ transplant recipients.
Tests were made on mice, marmoset monkeys, and dogs. Studies in the case of mice and marmoset monkeys have been positive with regard to anti- aging. The tests also revealed that the drug is safe and it was able to extend the life of middle-aged mice by up to 60%.
Two elderly dogs belonging to Paola Anderson and Sarah Godfrey were subjected to a treatment of rapamycin. The tests on dogs show the additional evidence of the anti-ageing properties of the drug, Rapamycin.
Prior the treatment the dogs were barely able to walk because of aging. The intake of the drug Rapamycin has renewed the strength and vitality, as the dogs now are able to run and play around.
Nevertheless, the drug still needs to undergo tests, so as to make it adaptable for human beings. At present, the drug is considered to have side effects that include cancer, diabetes, infections and more. It is thereby a necessity to make sure it stands effectively in human beings.
Numerous studies focused on rapamycin treatments for humans reveal that they “raise the possibility that (rapamycin) may have beneficial effects” on immune function.
Studies have been performed with regard to the side effects that the usage of rapamycin might have in humans. The side effects can be managed, said study’s lead Dr. Monica Mita.
Mita in an article published in Targeted Oncology said, “The rapamycin story is one of the most surprising, enticing, satisfying and unique stories in the history of medicine.”